As of Aug 03
| -1.68 / -4.56%|
The 7 analysts offering 12-month price forecasts for Horizon Pharma PLC have a median target of 42.00, with a high estimate of 48.00 and a low estimate of 37.00. The median estimate represents a +19.42% increase from the last price of 35.17.
The current consensus among 7 polled investment analysts is to Buy stock in Horizon Pharma PLC. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.